Back to Archive
Biology

Lithium as a new possible treatment for Alzheimers disease

Abigail Lee February 17, 2026
Lithium as a new possible treatment for Alzheimers disease

What if the metal used in batteries and thermonuclear weapons could help reverse the symptoms of one of the most devastating brain diseases in the world? A recent study has found a link between Alzheimer’s and lithium in the brain; scientists are now exploring the possibility of treating Alzheimer’s disease with lithium.

Alzheimer’s Disease (AD) is a progressive brain disease that causes cognitive decline and affects memory, thinking, and behavior. Alzheimer’s disease is quite common, especially in older age groups, and is difficult to live with. Those with Alzheimer’s often find themselves confused, suffering from memory lapses that disrupt their daily tasks. Sometimes, caretakers are needed to help them with even the simple task of remembering to have a meal. As of now, there is no known cure for Alzheimer’s, only treatments that may help manage symptoms and slow down the progression of the disease.

Lithium was first truly linked to Alzheimer’s in the summer of 2025, when a team of researchers discovered that “[l]ithium was the only metal that had markedly different levels” in the brain and blood of those with cognitive impairment and those who are cognitively healthy (Dutchen, 2025). In those who were even mildly cognitively impaired, lithium levels were significantly lower. The researchers found that “endogenous lithium is dynamically regulated in the brain and contributes to cognitive preservation during ageing” (Aron et al., 2025). The depletion of lithium is caused by amyloid beta deposits, which are toxic and form deposits in the brain of Alzheimer’s patients, binding to lithium and decreasing its function in cognitive preservation (Aron et al., 2025).

Researchers then demonstrated lithium depletion’s association with Alzheimer’s. When the researchers reduced lithium from the diets of healthy mice, their brain lithium levels were brought down to levels of AD patients. These mice experienced “brain inflammation, loss of synaptic connections between neurons, and cognitive decline [including memory loss]” (Dutchen, 2025).

After confirming lithium’s correlation with Alzheimer’s, scientists attempted to find a way to replenish it. The mice went through replacement therapy with lithium orotate, a lithium salt whose molecular structure is resistant to amyloid binding and helps it treat lithium deficiency in the brain. Lithium orotate is more effective in mice than other tested lithium compounds, even at lower doses. This is important because higher concentrations of lithium have previously been shown to be toxic, especially in older individuals (Dutchen, 2025). In the mice, the lithium orotate successfully managed to “suppress AD-type pathology, neuroinflammation and synapse loss, and restore memory” (Aron et al, 2025).

The findings of this study present a new hope to many. While the effects of lithium have not yet been proven in humans, if future clinical trials show the efficacy of lithium treatment on Alzheimer’s symptoms, the future of brain health could forever be changed. Bruce Yanker, one of the authors of the study by Harvard Medical School, said, “My hope is that lithium will [...] not just lessen but reverse cognitive decline and improve patients’ lives” (Dutchen, 2025). If further research confirms lithium is a viable and effective treatment option for Alzheimer’s, millions of patients may have the opportunity to regain cognitive function and live out their daily lives without Alzheimer’s debilitating symptoms.

Lithium, a New Possible Treatment for Alzheimer’s

By Abigail Lee


Abigail Lee